Drug discovery research
Conducts early-stage pre-clinical research and antibiotic development.
Fermalogic conducts early-stage drug discovery research and manufactures small molecules for research programs. Its work includes microbial natural products, macrolides, metabolic engineering, and fermentation co-product research. The company produces actinocores, molecular building blocks derived from actinomycetes through targeted or randomly generated mutations. Its first product is erythronolide B, and it also offers limited quantities of other erythromycin biosynthetic intermediates. Fermalogic's research has addressed biological strain and process improvements, antibiotic production, and recovery of fermentation co-products. Its products are made available to university researchers, biotech startups, and pharmaceutical companies. The company has operated in the Chicago area since 1991.
Disclosure: Profile information has been compiled from publicly available sources and has not yet been verified by the business.
From www.fermalogic.com, checked 22 Oct 2026. Only what the business states on its own website.
As listed by Fermalogic Inc. Prices as published by the business and may change.
Conducts early-stage pre-clinical research and antibiotic development.
Manufactures molecular cores for drug discovery programs.
Studies strain improvements and recovery of fermentation co-products.
No reviews yet — be the first to review Fermalogic Inc.
Own this business? Claim the page and get a review link and a QR code for your counter and receipts - reviews from your customers appear here.
Sign in to write a review
No password needed. We only use your email to confirm the review is genuine.
No reviews match this filter.
Tell our moderators what is wrong with the review by this reviewer and we will take a look.